These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4975544)

  • 1. Some comparative aspects of rifampicin and isoniazid.
    Canetti G; Le Lirzin M; Porven G; Rist N; Grumbach F
    Tubercle; 1968 Dec; 49(4):367-76. PubMed ID: 4975544
    [No Abstract]   [Full Text] [Related]  

  • 2. Resistance to rifampicin and isoniazid in strains of Mycobacterium tuberculosis.
    Siddiqi SH; Aziz A; Reggiardo Z; Middlebrook G
    J Clin Pathol; 1981 Aug; 34(8):927-9. PubMed ID: 6792243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suitability of rifampicin for intermittent administration in the treatment of tuberculosis.
    Dickinson JM; Mitchison DA
    Tubercle; 1970 Mar; 51(1):82-94. PubMed ID: 4992976
    [No Abstract]   [Full Text] [Related]  

  • 4. Correlation of in vitro and in vivo kinetics with clinical use of isoniazid, ethambutol, and rifampin.
    Jenne JW; Beggs WH
    Am Rev Respir Dis; 1973 Jun; 107(6):1013-21. PubMed ID: 4197230
    [No Abstract]   [Full Text] [Related]  

  • 5. [Sensitivity to rifampicin and ethambutol of mycobacteria resistant to isoniazid or streptomycin].
    Golychevskaja VI
    G Ital Chemioter; 1972; 19(2):20-2. PubMed ID: 4199029
    [No Abstract]   [Full Text] [Related]  

  • 6. Primary antituberculosis drug resistance and acquired rifampicin resistance in Gujarat, India.
    Trivedi SS; Desai SG
    Tubercle; 1988 Mar; 69(1):37-42. PubMed ID: 3140458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Critical concentration for definition of rifampicin resistance of tubercle bacilli].
    Tsukamura M
    Kekkaku; 1972 May; 47(5):113-9. PubMed ID: 4625369
    [No Abstract]   [Full Text] [Related]  

  • 8. Mutant prevention concentration of isoniazid, rifampicin and rifabutin against Mycobacterium tuberculosis.
    Rodríguez JC; Cebrián L; Ruiz M; López M; Royo G
    Chemotherapy; 2005 May; 51(2-3):76-9. PubMed ID: 15870500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Emergent strains of rifampicin-resistant Mycobacterium tuberculosis complex and susceptibility to isoniazid].
    Cacho-Calvo J; Martín-Díaz A;
    Enferm Infecc Microbiol Clin; 2013; 31(7):486-7. PubMed ID: 23623580
    [No Abstract]   [Full Text] [Related]  

  • 10. Comment on: isoniazid and rifampicin resistance-associated mutations in Mycobacterium tuberculosis isolates from Yangon, Myanmar: implications for rapid molecular testing.
    Köser CU; Summers DK; Archer JA
    J Antimicrob Chemother; 2011 Mar; 66(3):686-7; author reply 687. PubMed ID: 21177677
    [No Abstract]   [Full Text] [Related]  

  • 11. [Determination of resistance of Mycobacterium tuberculosis against isonicotinic acid hydrazide, streptomycin, para-aminosalicylic acid, ethionamide, ethambutol and rifampicin using the 32 P incorporation test].
    Reutgen H
    Acta Biol Med Ger; 1973; 30(3):309-16. PubMed ID: 4202698
    [No Abstract]   [Full Text] [Related]  

  • 12. Increasing drug resistance of Mycobacterium tuberculosis isolates in Ontario, Canada, 1987-1998.
    Remis RS; Jamieson F; Chedore P; Haddad A; Vernich L
    Clin Infect Dis; 2000 Aug; 31(2):427-32. PubMed ID: 10987700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the FluoroType MTBDR Assay for Detection of Rifampin and Isoniazid Resistance in Mycobacterium tuberculosis Complex Isolates.
    Hillemann D; Haasis C; Andres S; Behn T; Kranzer K
    J Clin Microbiol; 2018 Jun; 56(6):. PubMed ID: 29593055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary and acquired drug resistance in Mycobacterium tuberculosis strains in western region of Libyan Arab Jamahiriya.
    Elghoul MT; Joshi RM; Rizghalla T
    Trop Geogr Med; 1989 Oct; 41(4):304-8. PubMed ID: 2517554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study of the biological characteristics of strains of M. tuberculosis resistant to isoniazid and rifampin].
    Diaconescu C; Iacob L
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1984; 33(2):151-62. PubMed ID: 6093222
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experimental antitubercular activity of rifampicin, a derivative of rifamycin SV].
    Grumbach F; Rist N
    Rev Tuberc Pneumol (Paris); 1967; 31(6):749-62. PubMed ID: 4988378
    [No Abstract]   [Full Text] [Related]  

  • 17. Molecular characterization of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Kazakhstan.
    Kozhamkulov U; Akhmetova A; Rakhimova S; Belova E; Alenova A; Bismilda V; Chingissova L; Ismailov S; Ramanculov E; Momynaliev K
    Jpn J Infect Dis; 2011; 64(3):253-5. PubMed ID: 21617314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analytical and clinical performance characteristics of the Abbott RealTime MTB RIF/INH Resistance, an assay for the detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis in pulmonary specimens.
    Kostera J; Leckie G; Tang N; Lampinen J; Szostak M; Abravaya K; Wang H
    Tuberculosis (Edinb); 2016 Dec; 101():137-143. PubMed ID: 27865383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of tuberculostatic activity and blood concentration of new agents--rifampicin and ethambutol--in patients with pulmonary tuberculosis].
    Mkrtchian SV; Ushkin VV
    Antibiotiki; 1971 May; 16(5):472-7. PubMed ID: 5002224
    [No Abstract]   [Full Text] [Related]  

  • 20. [First clinical isolate of Mycobacterium tuberculosis exhibiting resistance to rifampicin and sensibility to isoniazid in the Elche´s Health Department-General Hospital(1998-2015)].
    Ruiz-García MM; Grau Delgado J; Andrés Franch MI; Prats Sánchez I
    Rev Esp Quimioter; 2017 Feb; 30(1):55-56. PubMed ID: 27883163
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.